How HIV treatment works, and what U=U really means
Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
In 1987 there was one HIV drug and it barely worked. Today a single daily pill, or in some cases an injection every two months, keeps the virus down for life in most people who take it.
The reason combination treatment works, and single drugs did not, is written into the biology of the virus.
Related pages: HIV
The bottom line
- Treatment combines drugs that block different steps of the viral life cycle.
- Most people reach an undetectable viral load within about six months, often sooner.
- A sustained undetectable viral load means HIV is not transmitted to sexual partners. This is U=U.
- Treatment is lifelong. Stopping leads to viral rebound within weeks.
- Whether long-acting injections can eventually replace daily pills for most people.
- How much of the extra heart and metabolic risk seen with long-term treatment comes from the drugs, from the virus, or from inflammation.
The story, step by step
What the evidence labels mean
One drug fails, three do not
What happens
The virus mutates constantly, so a single drug selects for the variant that resists it within weeks.
What the research shows
- Early single-drug treatment with AZT worked briefly and then failed as resistance emerged.
- Combination treatment arrived in 1996 and changed HIV from a usually fatal illness into a manageable one, almost overnight.
- The logic is arithmetic: a virus that needs several simultaneous mutations to escape three drugs at once will almost never manage it.
- Most modern regimens are two or three drugs in a single pill taken once a day.
Why it matters
The 1996 turn is one of the sharpest drops in death rate from any disease in modern medicine.
What's still uncertain
- Resistance can still develop, usually when doses are missed often enough to leave drug levels too low to suppress but high enough to select.
Read more
Next: The drug classes
Each one jams a different step
What happens
The names are off-putting, but each class simply blocks one stage of the cycle described on our life-cycle page.
What the research shows
- Entry and attachment inhibitors stop the virus getting into the cell at all.
- Nucleoside and non-nucleoside reverse transcriptase inhibitors stop viral RNA being copied into DNA.
- Integrase inhibitors stop the viral DNA being spliced into the chromosome. These are the backbone of most first-line treatment now.
- Protease inhibitors stop new particles being cut into their working form, so what buds out is harmless.
- Capsid inhibitors, the newest class, interfere with the protein shell. Lenacapavir, given twice a year, is the first.
Why it matters
Knowing which step a drug blocks explains why missing doses matters: the moment drug levels fall, the step reopens.
What's still uncertain
- No class removes viral DNA that is already integrated. That is why treatment controls HIV rather than curing it.
Read more
- NIAID: HIV replication cycleGovernment
- OwieClear: How HIV targets CD4 T-cellsOwieClear
Next: U=U
Undetectable means untransmittable, sexually
What happens
This is the most consequential finding in HIV in thirty years, and it is still not widely known.
What the research shows
- Large studies, including PARTNER, PARTNER2 and Opposites Attract, followed thousands of couples where one partner had HIV with an undetectable viral load and the other did not.
- Across tens of thousands of acts of sex without condoms, there were no transmissions linked to the partner with HIV.
- Undetectable here means a sustained viral load below the test's limit, usually under 200 copies per millilitre, confirmed by regular testing.
- Condoms still matter for preventing other sexually transmitted infections and pregnancy.
Why it matters
U=U is not encouragement or reassurance. It is a measured result, and it has changed how people with HIV live, date and disclose.
What's still uncertain
- The evidence is strongest for sexual transmission. Risk through shared needles and through breastfeeding is greatly reduced by an undetectable viral load but is not established as zero.
Read more
- CDC: About HIVGovernment
- OwieClear: The stages of HIV infectionOwieClear
Next: Prevention
PrEP before, PEP after
What happens
The same drugs that treat HIV also prevent it.
What the research shows
- PrEP is taken by people who do not have HIV. Daily pills reduce the risk of getting HIV from sex by about 99 percent when taken as prescribed.
- Injectable PrEP exists: cabotegravir every two months, and since 2025 lenacapavir twice a year, which the CDC recommended as a PrEP option in September 2025.
- PEP is emergency treatment after a possible exposure. It must start within 72 hours, and sooner is better, taken for 28 days.
- After sexual assault, go to an emergency department straight away and ask for PEP.
Why it matters
The 72-hour window for PEP is the single most time-sensitive fact on this page. If you are inside it, stop reading and go.
What's still uncertain
- Long-acting PrEP is far more expensive than generic daily pills, and access varies widely.
Read more
- CDC: PrEPGovernment
- CDC: About HIVGovernment
Next: Pregnancy and feeding
What current guidance actually says
What happens
This is an area where guidance changed recently and a lot of written material is out of date.
What the research shows
- Treatment during pregnancy that keeps the viral load undetectable makes transmission to the baby very unlikely.
- Since January 2023, US guidance no longer tells people with HIV not to breastfeed. People on treatment with a sustained undetectable viral load are counselled on all options, including formula, banked donor milk and breastfeeding, and supported in their choice.
- The risk of transmission through breastfeeding with sustained viral suppression is under one percent, which is low but not zero, unlike sexual transmission.
- Babies exposed to HIV are tested on a schedule, with a final test after breastfeeding stops.
Why it matters
If you have read older material saying people with HIV must not breastfeed, that was the guidance for decades and it changed. Discuss it with an HIV clinician rather than relying on anything written before 2023.
What's still uncertain
- This is current US guidance. Recommendations differ in other countries and by access to clean water, formula and reliable treatment.
Read more
More plain-language reading
- OwieClear: The stages of HIV infectionOwieClear
- OwieClear: Why HIV has no cure yetOwieClear
- OwieClear: What HIV does to the gutOwieClear